Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of VINLAZINE 75 versus EFEXOR XR under fasting conditions
TCTR20261009001Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of venlafaxine (2 arms), sponsored by Government Pharmaceutical Organization. Primary endpoints: Cmax of venlafaxine, AUC0-t of venlafaxine and 1 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
venlafaxine
Beyond the preview
Go deeper on TCTR20261009001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261009001.